Rimegepant
- Product Name
- Rimegepant
- CAS No.
- 1289023-67-1
- Chemical Name
- Rimegepant
- Synonyms
- BMS-927711;BMS 927711;CS-2806;BHV-3000;BMS 92771;Rimegepan;Remazepam;Rimegepant;BMS927711;BMS 927711;BMS-927711(Rimegepant)
- CBNumber
- CB42645135
- Molecular Formula
- C28H28F2N6O3
- Formula Weight
- 534.56
- MOL File
- 1289023-67-1.mol
Rimegepant Property
- Density
- 1.45±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- Soluble in DMSO
- form
- A crystalline solid
- pka
- 12.03±0.20(Predicted)
N-Bromosuccinimide Price
- Product number
- 26338
- Product name
- Rimegepant
- Packaging
- 1mg
- Price
- $43
- Updated
- 2023/06/20
- Product number
- 26338
- Product name
- Rimegepant
- Packaging
- 5mg
- Price
- $189
- Updated
- 2023/06/20
- Product number
- 26338
- Product name
- Rimegepant
- Packaging
- 10mg
- Price
- $334
- Updated
- 2023/06/20
- Product number
- 26338
- Product name
- Rimegepant
- Packaging
- 25mg
- Price
- $678
- Updated
- 2023/06/20
- Product number
- R517100
- Product name
- Rimegepant
- Packaging
- 500mg
- Price
- $15225
- Updated
- 2021/12/16
Rimegepant Chemical Properties,Usage,Production
Description
Rimegepant (Nurtec ODT)(FDA approved in February 2020) is an ODT available in a single strength of 75 mg for the acute treatment of migraine with or without aura in adults.No more than 75 mg should be taken in a 24-hour period. while there are no contraindications，concomitant administration with CYP3A4 inhibitors should be avoided.The most common adverse reaction is nausea, occurring in few patients (rimegepant PI, 2020). In clinical trials, a single 75-mg dose of rimegepant demonstrated superiority over placebo with regard to freedom from pain (21% in the rimegepant group vs.11% in the placebo group) and freedom from the most bothersome symptom (35% vs. 27%) at 2 hours post dose (Croop et al., 2019). Rimegepant is not approved for migraine prevention, although it is presently in late-stage clinical trials assessing it for that indication(NCT03732638,2020).
Uses
Rimegepant is an oral calcitonin gene-related peptide (CGRP) receptor antagonist used for the treatment of migraine.
Rimegepant Preparation Products And Raw materials
Raw materials
Preparation Products
Rimegepant Suppliers
- Tel
- +1 (866) 930-6790
- Fax
- +1 (866) 333-9607
- info@adooq.com
- Country
- United States
- ProdList
- 2784
- Advantage
- 58
- Tel
- +1-800-259-7612
- Fax
- +1-800-259-7612
- info@musechem.com
- Country
- United States
- ProdList
- 4662
- Advantage
- 60
- Tel
- +1-708-310-1919 +1-13798911105
- Fax
- 708-557-7486
- sales@invivochem.cn
- Country
- United States
- ProdList
- 6393
- Advantage
- 58
- Tel
- +1 (732)236-3202
- sales@cckinase.com
- Country
- United States
- ProdList
- 2738
- Advantage
- 58
- Tel
- +1-833-552-7181
- sales@aladdinsci.com
- Country
- United States
- ProdList
- 57511
- Advantage
- 58
- Tel
- +1-781-999-5354
- support@targetmol.com
- Country
- United States
- ProdList
- 19973
- Advantage
- 58
- Tel
- 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 9926
- Advantage
- 65
View Lastest Price from Rimegepant manufacturers
- Product
- BMS-927711 1289023-67-1
- Price
- US $0.00/g
- Min. Order
- 1g
- Purity
- 98% HPLC
- Supply Ability
- 100kg
- Release date
- 2023-08-14
- Product
- Rimegepant 1289023-67-1
- Price
- US $20.00/KG
- Min. Order
- 1KG
- Purity
- 0.99
- Supply Ability
- 20
- Release date
- 2023-09-05
- Product
- Rimegepant 1289023-67-1
- Price
- US $150.00/kg
- Min. Order
- 1kg
- Purity
- 99.9%
- Supply Ability
- 10000MT
- Release date
- 2023-05-29